Biora Therapeutics, Inc. Deferred Offering Costs
Biora Therapeutics, Inc. had Deferred Offering Costs of $1.10 million as of 2019-12-31, per its 10-K filed 2021-03-18.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:DeferredOfferingCosts · last filed 2021-03-18
- 2019-12-31: Deferred Offering Costs $1.10M.
| Period end | Deferred Offering Costs |
|---|---|
| 2019-12-31 | $1.10M 10-K · filed 2021-03-18 |